L1 cell adhesion molecule high expression is associated with poor prognosis in surgically resected brain metastases from lung adenocarcinoma
- PMID: 35525225
- PMCID: PMC9092252
- DOI: 10.1016/j.clinsp.2022.100040
L1 cell adhesion molecule high expression is associated with poor prognosis in surgically resected brain metastases from lung adenocarcinoma
Abstract
Objectives: Accurate prognosis assessment across the heterogeneous population of brain metastases is very important, which may facilitate clinical decision-making and appropriate stratification of future clinical trials. Previous studies have shown the L1 Cell Adhesion Molecule (L1CAM) is potentially involved in human malignancies of multiple different samples and unfavorable survival. However, no data of L1CAM are available for the brain metastases from lung adenocarcinoma, especially for the one with neurosurgical resection.
Method: The authors investigated the L1CAM expression in cranial metastatic lesions for patients with brain metastases from lung adenocarcinoma after neurosurgical resection using tissue microarrays that were obtained from the Department of Neurosurgery at the Cancer Hospital of the Chinese Academy of Medical Sciences. Furthermore, the relationship between L1CAM expression and clinic-pathological parameters, including overall survival time, was analyzed to assess the prognostic value of L1CAM.
Results: L1CAM high expression was found in 62.30% of brain metastases from lung adenocarcinoma and significantly correlated with brain metastasis number (p = 0.028) and Lung-molGPA score (p = 0.042). Moreover, L1CAM expression was an independent predictor of survival for brain metastases after neurosurgical resection in a multivariate analysis. Patients with L1CAM high expression had unfavorable overall survival time (p = 0.016). In addition, the multivariate analysis also showed age and extracranial transfer were also the independent prognostic factors for this type of patient with brain metastases.
Conclusions: A subset of brain metastases from lung adenocarcinoma aberrantly expresses L1CAM. L1CAM is a novel independent prognostic factor for brain metastasis from lung adenocarcinoma after neurosurgical resection.
Keywords: Brain metastasis from lung cancer; L1 cell adhesion molecule; Neurosurgical resection; Prognostic factor.
Copyright © 2022 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.
Conflict of interest statement
Conflicts of interest This work was supported by grants from Beijing Xisike Clinical Oncology Research Foundation (Y-QL202101-0094), National Natural Science Foundation of China (82072803) and CAMS Innovation Fund for Medical Sciences (2021-I2M-1-012).
Figures


Similar articles
-
L1CAM expression in either metastatic brain lesion or peripheral blood is correlated with peripheral platelet count in patients with brain metastases from lung cancer.Front Oncol. 2022 Oct 27;12:990762. doi: 10.3389/fonc.2022.990762. eCollection 2022. Front Oncol. 2022. PMID: 36387224 Free PMC article.
-
Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis.Dis Markers. 2021 Dec 30;2021:8585633. doi: 10.1155/2021/8585633. eCollection 2021. Dis Markers. 2021. PMID: 35003395 Free PMC article.
-
L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.Mol Cancer. 2011 Oct 10;10:127. doi: 10.1186/1476-4598-10-127. Mol Cancer. 2011. PMID: 21985405 Free PMC article.
-
The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis.Arch Gynecol Obstet. 2024 Mar;309(3):789-799. doi: 10.1007/s00404-023-07149-8. Epub 2023 Jul 16. Arch Gynecol Obstet. 2024. PMID: 37454351
-
High L1CAM expression predicts poor prognosis of patients with endometrial cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2021 Apr 2;100(13):e25330. doi: 10.1097/MD.0000000000025330. Medicine (Baltimore). 2021. PMID: 33787629 Free PMC article.
Cited by
-
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.Ther Adv Med Oncol. 2024 Nov 4;16:17588359241293951. doi: 10.1177/17588359241293951. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39502403 Free PMC article.
-
L1CAM expression in either metastatic brain lesion or peripheral blood is correlated with peripheral platelet count in patients with brain metastases from lung cancer.Front Oncol. 2022 Oct 27;12:990762. doi: 10.3389/fonc.2022.990762. eCollection 2022. Front Oncol. 2022. PMID: 36387224 Free PMC article.
-
Detecting tipping points of complex diseases by network information entropy.Brief Bioinform. 2024 May 23;25(4):bbae311. doi: 10.1093/bib/bbae311. Brief Bioinform. 2024. PMID: 38960408 Free PMC article.
-
LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis.Thorac Cancer. 2023 Feb;14(4):407-418. doi: 10.1111/1759-7714.14760. Epub 2022 Dec 14. Thorac Cancer. 2023. PMID: 36516959 Free PMC article.
-
Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status.Heliyon. 2023 Jun 22;9(6):e17495. doi: 10.1016/j.heliyon.2023.e17495. eCollection 2023 Jun. Heliyon. 2023. PMID: 37408903 Free PMC article.
References
-
- Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. - PubMed
-
- Boire A, Brastianos PK, Garzia L, Valiente M. Brain metastasis. Nat Rev Cancer. 2020;20(1):4–11. - PubMed
-
- Soffietti R, Ahluwalia M, Lin N, Ruda R. Management of brain metastases according to molecular subtypes. Nat Rev Neurol. 2020;16(10):557–574. - PubMed
-
- Raveh S, Gavert N, Ben-Ze'ev A. L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 2009;282(2):137–145. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical